F13.939
Sedative, hypnotic or anxiolytic use, unspecified with withdrawal, unspecified
Clinical Classification Guidelines
Medical Intelligence & Overview
ICD-10 Code F13.939 refers to cases involving the use of sedative, hypnotic, or anxiolytic medications, where withdrawal symptoms occur but are not specifically classified. These medications are commonly prescribed to help with anxiety, sleep difficulties, and other related conditions. However, their misuse or abrupt discontinuation can lead to withdrawal, which can be challenging and requires proper management.
Causes & Symptoms
Clinical Causes: Prolonged or excessive use of sedative, hypnotic, or anxiolytic medications Dependence on these medications due to regular use Sudden cessation or reduction of the medication intake Misuse or recreational use beyond prescribed guidelines Inadequate medical supervision during treatment
Key Symptoms: Anxiety or agitation Insomnia or disturbed sleep Irritability Tremors or shakiness Sweating Nausea or vomiting Headaches Palpitations or rapid heartbeat Dizziness or lightheadedness Potential seizures in severe cases
Diagnostic & Treatment
Diagnosis Path: Diagnosis involves a thorough medical history review, including medication usage patterns and recent changes. Healthcare providers may perform physical examinations and look for withdrawal symptoms. In some cases, laboratory tests may be used to rule out other conditions or assess medication levels. The healthcare provider assesses the timing of symptoms relative to medication discontinuation or dose reduction to confirm withdrawal.
Treatment Protocols: Treatment strategies aim to safely manage withdrawal symptoms and prevent complications. These often include:
Clinical Advice & FAQs
Billing Guidance
Is F13.939 a billable ICD-10 code?
Yes, F13.939 is a specific, billable code that can be used to indicate a diagnosis for reimbursement purposes.
Documentation
How do I report F13.939?
Clinical documentation must specify the nature of Sedative, hypnotic or anxiolytic use, unspecified with withdrawal, unspecified and any associated comorbidities for accurate reporting.
Cite this Clinical Reference